Depression Mental and Behavioural Disorders Depression
Conditions
Interventions
Participants are randomised to the one of three study arms by specific software.
Study arm 1: Intervention Group (Combined boulder and psychotherpay)
Participants receive therapy in groups of ten th
Sponsors
OH-DO-KWAN Stiftung Ludmilla Pankofer und Carl Wiedmeier
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Current Inclusion Criteria as of 13/03/2018: 1. Depression, measured by the score of the PHQ-9 (Cut-off = 8) 2. Informed Consent to participate in the study (especially regarding randomised allocation and data acquisition) 3. Possibility to come to the therapy locations Previous Inclusion Criteria: 1. Depression, measured by the score of the PHQ-9 (Cut-off = 10) 2. Informed Consent to participate in the study (especially regarding randomised allocation and data acquisition) 3. Possibility to come to the therapy locations
Exclusion criteria
Exclusion criteria: Current exclusion criteria as of 13/03/2018: 1. Acute suicidality 2. Severe psychiatric disorder (psychosis, mania, substance-abuse) 3. Physical contraindication (physical disorders or pregnancy) 4. BMI 40 5. Age 35 5. Age < 18 years 6. Actual participation in group psychotherapy 8. Start of psychiatric medication within the last 8 weeks 9. Planned in-Patient stay during therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression is measured using the score of an observer-rating-scale (Montgomery Asberg Rating Scale, MADRS) by computer-assisted telephone interviews (CATI) at baseline, ten weeks, three, six and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Attitude towards the own body/body image is measured using scale "Vitale Körperdynamik" of the Fragebogen zum Körperbild (FKB-20) at baseline, ten weeks, three, six and 12 months 2. Anxiety is measured using Generalizied Anxiety Disorder Scale-7 (GAD-7) at baseline, ten weeks, three, six and 12 months 3. Social Phobia is measured using scale interpersonal sesitivity of the Symptom-Checklist (SCL-90-R) at baseline, ten weeks, three, six and 12 months 4. Avoidance Behavior is measured using the Items of the scale Mobility Inventory (MI) of the "Fragebogen zu körperbezogenen Ängsten, Kognitionen und Vermeidung (AKV)" at baseline, ten weeks, three, six and 12 months 5. Self-esteem is measured using the Rosenberg self-esteem scale (RSE) at baseline, ten weeks, three, six and 12 months 6. Self-efficacy is measured using the Skala zur Allgemeinen Selbstwirksamkeit (SWE) at baseline, ten weeks, three, six and 12 months 7. Coping is measured using the Coping-scale of the "Fragebogen zur Erfassung von Ressourcen und Selbstmanagementfähigkeiten (FERUS) at baseline, ten weeks, three, six and 12 months | — |
Countries
Germany
Outcome results
None listed